Systemic neuroscience
Neuromuscular studies
Specialisation | Systemic neurosciences (neuromuscular diseases) |
Indication | Hereditary transthyretin-mediated amyloid polyneuropathy |
Short title | ION-682884-CS13 |
Study title | Extension study to evaluate the long-term safety and efficacy of ION-682884 in patients with hereditary transthyretin-mediated amyloid polyneuropathy |
Brief description | Evaluation of the long-term safety and efficacy of ION-682884 in patients with hereditary transthyretin-mediated amyloid polyneuropathy |
Phase | IIIb |
EudraCT-Number | 2021-001427-40 |
Status | finalised |
Contact | Study director: Prof Dr Markus Weiler Phone: 06221-567504 E-mail: markus.weiler(at)med.uni-heidelberg.de Study coordination: Sandra Schmich Tel: 06221 56-37194 Fax: 06221 56-5935 |
Specialisation | Systemic neurosciences (neuromuscular diseases) |
Indication | Hereditary transthyretin amyloidosis |
Short title | ACT-EARLY (AG10-501) |
Study title | A randomised, multicentre, double-blind, placebo-controlled phase III study for the prevention of transthyretin amyloidosis in young people with acoramidis |
Brief description | A phase III, randomised, multicentre, double-blind, placebo-controlled trial for the prevention of transthyretin amyloidosis with acoramidis in people with a confirmed variant in the transthyretin gene. |
Phase | PHASE III |
EudraCT-Number | 2024-513547-82 |
Status | Open, recruitment from Q2 / 2025 |
Contact | Study management: Prof Dr Markus Weiler Phone: 06221-567504 E-mail: markus.weiler(at)med.uni-heidelberg.de Study coordination: Sandra Schmich Tel: 06221 56-37194 Fax: 06221 56-5935 |
Specialisation | Systemic neurosciences (neuromuscular diseases) |
Indication | 5q Spinal muscular atrophy |
Short title | ASCEND |
Study title | Study to evaluate higher dose nusinersen (BIIB058) in patients with spinal muscular atrophy previously treated with risdiplam |
Brief description | Evaluation of higher dose nusinersen (BIIB058) in patients with spinal muscular atrophy previously treated with risdiplam |
Phase | IIIb |
EudraCT-Number | 2021-001294-23 |
Status | Open, recruitment ongoing |
Contact person | Study management: Prof Dr Markus Weiler Phone: 06221-567504 E-mail: markus.weiler(at)med.uni-heidelberg.de Study coordination: Sandra Schmich Tel: 06221 56-37194 Fax: 06221 56-5935 |
Specialisation | Systemic neurosciences (neuromuscular diseases) |
Indication | 5q Spinal muscular atrophy |
Short title | SMArtCARE |
Study title | Follow-up and therapy evaluation in spinal muscular atrophy |
Short description | Follow-up and therapy evaluation in spinal muscular atrophy |
Phase | n. a. |
EudraCT-Number | n. a. |
Status | Open, recruitment ongoing |
Contact person | Study management: Prof Dr Markus Weiler Phone: 06221-567504 E-mail: markus.weiler(at)med.uni-heidelberg.de Study coordination: Sandra Schmich Tel: 06221 56-37194 Fax: 06221 56-5935 |
Specialisation | Systemic neurosciences (neuromuscular diseases) |
Indication | Amyotrophic lateral sclerosis (ALS) and other motor neurone diseases |
Short title | EARLY-ALS |
Study title | Study to investigate early symptoms in patients with amyotrophic lateral sclerosis and other motor neurone diseases |
Short description | Investigation of early symptoms in patients with amyotrophic lateral sclerosis and other motor neurone diseases |
Phase | n.a. |
EudraCT-Number | n.a. |
Status | Open, recruitment ongoing |
Contact person | Study management: Prof Dr Markus Weiler Phone: 06221-567504 E-mail: markus.weiler(at)med.uni-heidelberg.de Study coordination: Sandra Schmich Tel: 06221 56-37194 Fax: 06221 56-5935 |
Specialisation | Systemic neurosciences (neuromuscular diseases) |
Indication | Amyotrophic lateral sclerosis (ALS) and other motor neurone diseases |
Short title | TEAR-ALS |
Study title | Study to analyse biomarkers from tear fluid in patients with amyotrophic lateral sclerosis and other motor neuron diseases |
Short description | Analysis of biomarkers from tear fluid in patients with amyotrophic lateral sclerosis and other motor neurone diseases |
Phase | n.a. |
EudraCT-Number | n.a. |
Status | Open, recruitment is ongoing. |
Contact | Study director: Prof Dr Markus Weiler Tel: 06221-567504 E-mail: markus.weiler(at)med.uni-heidelberg.de Study coordination: Sandra Schmich Tel: 06221 56-37194 Fax: 06221 56-5935 |
Specialisation | Systemic neurosciences (neuromuscular diseases) |
Indication | Amyotrophic lateral sclerosis (ALS) |
Study title | Deficits and potential for improvement in the psychosocial and palliative care of ALS patients in Germany |
Brief description | Multicentre, questionnaire-based study to assess satisfaction with palliative, including psychosocial care for ALS patients in Germany |
Phase | n.a. |
EudraCT-Number | n.a. |
Status | Open, recruitment is ongoing. |
Contact | Study director: Prof Dr Markus Weiler Phone: 06221-567504 E-mail: markus.weiler(at)med.uni-heidelberg.de Study coordination: Sandra Schmich Tel: 06221 56-37194 Fax: 06221 56-5935 |